Background. Most hypertensive patients are managed in primary care in Denmark, but previous studies have shown that only 21-43% of hypertensive patients achieve optimal blood pressure (BP) control. Antihypertensive drug treatment, risk factors and cardiovascular disease (CVD) are some of the important factors to consider when optimizing the individual treatment strategy in hypertensive patients. Objective. To examine treatment of BP according to Danish guidelines (BP < 140/90 mmHg generally and <130/80 mmHg for diabetics) in a population from general practice in relation to risk factors, CVD and diagnosis of diabetes.
Introduction
Hypertension is a common condition with a prevalence of 20% in the adult Danish population and an important risk factor for cardiovascular disease (CVD). [1] [2] [3] [4] [5] Diagnosis and treatment of hypertension and blood pressure (BP) measurements are in Denmark primarily carried out in general practice, and hypertension accounts for 27% of contacts to general practice by patients with chronic diseases. 6, 7 Previous studies have shown that 21-43% of hypertensive patients in Denmark do not reach target BP of <140/90 mmHg in general and <130/80 mmHg for diabetics. 1, 4, [8] [9] [10] However, mortality from stroke and ischemic heart diseases significantly decreases when BP is lowered, which further stresses the importance of optimal BP control. 11, 12 When planning an individual treatment strategy, it is important to consider risk factors, CVD and appropriate antihypertensive drug treatment, [13] [14] [15] [16] [17] but little is known on these matters on a general practice populations level. Hence, the aim of the present study were to analyse treatment of BP according to Danish guidelines (BP < 140/90 mmHg generally and <130/80 mmHg for diabetics) in a population from general practice in relation to risk factors, CVD and diabetes diagnosis.
Methods

Study design
In the period November 2007 to January 2008, we included 184 general practices and 5413 hypertensive patients in a cross-sectional study. The GPs consecutively included patients with known hypertension if the consultation included a BP measurement. Patients being investigated for hypertension or patients with newly diagnosed hypertension could not be included. The consultation could be a planned BP measurement or it could be a consultation about another topic, but BP measurement should be included in the consultation. The GP registered information about each patient's risk factors, CVD, diagnosis of diabetes and antihypertensive drug treatment. The patients completed a questionnaire on risk factors after the consultation.
Settings
The general practices were recruited from three of five regions in Denmark: 82 from the Capital Region of Denmark, 52 from Region Zealand and 50 from the Region of Southern Denmark.
Danish health care
Denmark has a tax-funded healthcare system, providing free access to general practice, outpatient clinics and hospital care for all citizens. A total of 98% of the 5.5 million Danish citizens are registered with a general practitioner and receive free medical care (www.denmark.dk). Prescription medications are partly subsidized.
Audit Project Odense
Data for the present study were collected during an audit on hypertension carried out by Audit Project Odense (APO). APO is a quality improvement concept widely used in many countries. [18] [19] [20] It includes registration of the GP's activities, courses, follow-up and evaluation of their treatment patterns. During the consultation, the GPs register information about patients' characteristics and treatment on an APO registration chart.
Guidelines
In November 2007, the GPs in Denmark had access to two national guidelines on treatment and control of hypertension. The first, from 2004, was provided by the Danish Hypertension Society and risk estimation were based on a patient's overall risk for a cardiovascular event modified after the European Society of Hypertension and the European Society of Cardiology guidelines from 2003. 16 The second, from 2007, was provided by the Danish Society of GPs, and a patient's overall risk of cardiovascular death was estimated using the SCORE system. 17 Risk factors like age, smoking, cholesterol blood level and systolic BP were used in both guidelines. Both guidelines recommended the same target BP <140/90 mmHg in general and BP <130/80 mmHg for diabetics, home BP <135/85 mmHg in general and <130/80 mmHg in diabetics. Antihypertensive drug treatment was in both guidelines recommended to be combination therapy using diuretics, calcium channel blockers, beta blockers, angiotensinconverting enzyme (ACE) inhibitors and angiotensinreceptor blockers (ARB). For diabetics, ACE inhibitors or ARB were the first choices in a combination with additional one or two other antihypertensive drugs. Recommendations for BP measurement were that office BP should be measured with at least two measurements with a maximum of 5 mmHg difference measured with the patients sitting down resting for 5 minutes and using a cuff properly adapted to the arm size. 21 The mean of the last two BP measurements should be transferred to the patient medical record.
Patient questionnaire
The patient questionnaire was developed by the authors based on literature review and clinical experience and subsequently pilot tested. It included questions about smoking status (never, current or former smoker indicating the year in which the patient stopped smoking), alcohol intake (0 U/week, 1-8 U/week, 9-20 U/week, 20-50 U/week and >50 U/week), weight and height. Only minor changes were made after the pilot test.
Participants
Overall, 7111 hypertensive patients were invited to participate during a consultation with their GP and 5413 patients returned the questionnaire by which they accepted to participate.
Data sources and measurements
The GPs were instructed to follow the above-mentioned guidelines for BP measurements. 21 The GP had to calculate the mean of the last two BP measurements since she/he could only register one value for office BP on the APO registration chart. If a home BP measurement was available from the actual consultation or if it was registered in the medical records within the last 6 months, the GP was allowed to transfer a home BP to the registration chart.
Variables
On the APO registration chart, the GP recorded duration of hypertension (years), risk factors (familial history of CVDs, hypercholesterolemia if total cholesterol was >5.0 mmol/l or >4.5 mmol/l for diabetics and too 
Analyses
Patients were categorized into three groups: hypertension without CVD or diabetes, hypertension with CVD but without diabetes and hypertension with diabetes. The latter group of diabetics included patients with and without CVD. In analyses of optimal BP control, we used office BP. Some 153 patients only had a home BP registered on the APO registration chart. A home BP could be up to 6 months old and since we did not have a date for the home BP, it was not included in analyses of optimal BP control.
Statistical analyses
Proportion and mean values were presented with 95% confidence intervals (CIs). We used linear regression to test for trend between systolic and diastolic BP and gender. We used logistic regression to test for association between binary variables and gender. Multinomial logistic regression was used to test for association between categorical variables and gender, when the outcome had more than two levels. All regression analyses were adjusted for age and for cluster effect at practice level using robust cluster estimation. We used logistic regression to age and gender adjust the association between hypertension categories and antihypertensive drug class and between hypertension categories and optimal BP control. The reference group in these analyses was 'hypertension without CVD or diabetes'. Missing values were considered missing at random. STATA release 11.0 (StataCorp, College Station, TX) was used for all statistical analyses.
Ethics
Patients gave consent to participate in the study by answering the questionnaire. The study was approved by the Danish Data Protection Agency. The study did not need approval by the Regional Ethics Committee.
Results
In total, 5413 patients were included (2408 males and 3005 females). Mean age was 65.9 years (CI: 65.6-66.1). There were relatively more women than men in the older age groups (Fig. 1 ). Demographic information, BP, risk factors and treatment of the study population are presented in Table 1 . The majority of patients (54.7%, CI: 53.4-56.1) had hypertension for >5 years. Mean systolic office BP was higher than recommended by guidelines (143.1 mmHg CI: 142.7-143.6), while mean diastolic office BP was lower than treatment target (82.8 mmHg CI: 82.5-83.1). Overall, 29.1% (27.9-30.3) of the study population achieved optimal BP control.
Risk factors
Overall, 42.6% (41.2-43.9) of the study population had hypercholesterolemia with no significant difference between genders (Table 1) . Smoking was a risk factor in 22.5% (21.4-23.6) of the study population and women were more often non-smokers than men (46.0% for women and 26.5% for men). The proportion of men having a BMI <25 was 26.0% (24.2-27.7), while 42.9% (41.1-44.6) of the women had a BMI <25. Furthermore, men had a mean BMI of 27.9 (27.8-28.1), which was significantly higher than women (26.8 CI: 26.6-27.0). Table 1) . The majority of patients were treated with one (32.5%) or 2 (39.5%) antihypertensive drugs. Men had higher odds of being treated with ACE inhibitors, calcium channel blockers and other antihypertensive than women, and women had higher odds of being treated with diuretics than men. (Table 3) . Although 54.1% (CI: 50.7-57.5) of diabetics received an ACE inhibitor and 31.6% (CI: 28.4-34.7) received an ARB, a total of 17.7% (149 patients) of the diabetics were not treated with either of these. Of the 149 diabetics, 12.1% of these received no antihypertensive drugs despite a mean systolic office BP of 145.2 mmHg (134.8-155.6).
Hypertension categories
End-digit preference in BP values
The accumulation of BP measurements at the exact values 140/90 and 130/80 mmHg BP is known as 'enddigit preference'. It occurs when GPs round values up or down to multiples of 5 or 10. 22 There were 740 (16.7%) patients without diabetes, who had a systolic office BP value of exactly 140 mmHg and 737 (16.6%) had a diastolic office BP value of 90 mmHg. Since end-digit-preference was present in our study, we repeated our analyses using BP <141/91 mmHg in general and BP <131/81 mmHg for diabetics as optimal BP control. The overall proportion of patients achieving optimal BP control then increased from 29.1% to 47.8%, and men had lower odds of having optimal BP control than women (P = 0.028, adjusted for age). The analyses using BP <141/91 mmHg and BP <131/81 mmHg show the same trends and the results remained at the 5% significance level as described, when using BP <140/90 mmHg in general and BP <130/80 mmHg in diabetics.
Discussion
Principal findings Firstly, the proportion of patients achieving optimal BP control in treated hypertensive patients in general practice in Denmark is still too small. Only 29.1% of 5413 treated hypertensive patients achieved optimal BP control. Secondly, diabetics were less likely to achieve optimal BP control and 17.7% of diabetics were not treated with an ACE inhibitors or ARB and thirdly, the majority of hypertensive patients were only treated with one or two antihypertensive drugs. Diuretics and ACE inhibitors were the drugs most used.
Strengths and weaknesses
It is a strength that we used a data collection tool, which is known by the GPs and which they were accustomed to use. [18] [19] [20] [23] [24] [25] This optimized the consistency in the GPs' registration of the patient's data and enabled us to include a large Danish population of hypertensive patients from general practice. The study was part of a quality development for the individual practitioner; hence, the GP used data gathered from their own patients for learning purposes. They were encouraged to include all patients consecutively, and we have no reason to believe that the GPs deviated from the consecutive procedure for example by not including patients with a BP difficult to treat.
A potential bias is clustering of BP measurements $140/130 mmHg systolic or 90/80 mmHg diastolic due to end-digit preference as described earlier. End-digit preference probably occurs because many GPs in daily clinical practice consider BP values of 140/90 mmHg to be optimal BP control and more importantly as values that they do not have to act upon. However, optimal BP control increased from 29.1% to 47.8% when cut-off values at 140/90 and 130/80 were included in the analyses. End-digit preference could have underestimated the proportion of patients with optimal BP control in our study, if the GPs chose to record a systolic value of 140 mmHg, when the true reading was 138 or 139 mmHg systolic. However, the GPs could equally had registered a systolic value of 140 mmHg, when the true reading was a systolic value of 141 mmHg or higher and these patients would then be classified correctly in our study as not reaching optimal BP control. Since we did not make a quality check to describe if a GP rounded BP values up or down, we chose to keep BP level recommended by guidelines in our analyses and interpretation of our results.
We used the GPs' registration of antihypertensive drug treatment and not patients' self-reported drug treatment. We made agreement analyses between the GP's registration of a patient's antihypertensive drug treatment from the APO registration chart and whether a prescription for a specific antihypertensive drug class had been redeemed within the last year prior to November 2007. Information on redemption of prescriptions was taken from the Danish Register of Medical Product Statistics. Kappa values range from 0.73 (diuretics) to 0.80 (ARB), indicating good agreement and hence high validity of the GP's registration of a patient's drug treatment.
The patients included were only sampled over 4 weeks. Patients seeing their doctor often therefore have a higher possibility of being included in our study. Assuming that patients with BP >140/90 mmHg visit their doctor more often than patients with optimal BP control, this selection bias may potentially lead to an underestimation of patients achieving optimal BP control. The GPs participated on a voluntary basis and may be particularly interested in hypertension and quality development. However, according to the Danish Society of GPs' yearly practice count the GP population in our study was similar to GPs in the rest of Denmark with respect to age, gender and types of practices. We therefore believe that they do not Explanation and findings and comparison to other studies Other studies have found that treated hypertensive patients achieved BP <140/90 mmHg in 15-63% of the cases, and diabetics were also in these studies less likely to achieve BP <130/80 mmHg. 1, 4, [26] [27] [28] [29] [30] [31] [32] There are several reasons for not reaching optimal BP control. In some countries, BP >140/90 mmHg in treated patients is partly explained by lack of access to health care for some patients groups. [33] [34] [35] [36] However, Denmark has a health care system with equal access. Other studies attribute the lack of optimal BP control to the absence of national guidelines. 27, 33 In Denmark, guidelines for treatment and control of hypertension in primary care are well implemented and have existed since 1997. 8 However, although guidelines are well implemented, it is noteworthy that such a large proportion of patients have BP values of exactly 140 mmHg systolic or 90 mmHg diastolic (end-digit-preference), which changes the proportion of patients achieving optimal BP control from low to high (29.1-47.8%). Whether the GP rounded BP values up or down to 140/90 mmHg, this accumulation of BP values raises question on how the GPs consider BP limits recommended by guidelines and how they adapt these goals into daily clinical practice. It further raises the questions as to whether the GPs consider a BP of 140/90 mmHg as optimally controlled, and if they do, what BP values do they consider to be 'not optimally treated' and act upon. Inadequate treatment could be another explanation for BP >140/90 mmHg. 2, 12, [14] [15] [16] [17] The majority of patients in our study were only treated with one or two antihypertensive drugs although national and international guidelines recommend to escalate to combination therapy after monotherapy has failed or to combinations therapy as first-line therapy in patients with marked BP elevation and high CVD risk.
14-17 The reasons for not being intensively treated, for example by using more than two antihypertensive drugs, are probably complex and in addition to doctors' inertia, it involves patients' resistance to 'another pill', higher cost and fear of adverse reactions. Doctors' inertia could likewise be due to fear of additional side effects, priority to the treatment of comorbidity, polypharmacy, lack of belief in BP levels recommended by guidelines or lack of confidence in a significantly risk reduction by lowering a systolic BP from, e.g. 145-140 mmHg. Furthermore, this study is a cross-sectional study and the data cannot show whether patients had been well treated for several years, but for some reasons were above target BP, when included in the study. The GP could therefore be awaiting a development in BP level to higher or lower values, before acting upon it. However, the majority of hypertensive patients in our study had hypertension for >5 years and was treated with one or two antihypertensive drug classes without having a BP <140/90 mmHg (or BP <130/80 mmHg in diabetics). This leaves room for improvement.
In Denmark, three different guidelines recommend that all hypertensive diabetics should be treated with an ACE inhibitor or ARB. 16, 17, 37 However, 17.7% of diabetics in this study were still not treated with either of these. A very low proportion of diabetics achieved optimal BP control (10.9%) indicating that this patient group needs additional attention, in order to reach target BP.
A higher proportion of patients with CVD achieved optimal BP control (38.7%) than the overall study population (29.1%). The guideline from the Danish Hypertension Society has changed its recommendations for BP limits since this study began in November 2007. The new BP limits indicate that patients with stroke, former MI and other CVD should have a BP <130/80 mmHg. When using these new limits on data from this study population, only 10.9% of patients with CVD achieve optimal BP control compared to 38.7% when BP limits were <140/90 mmHg. This is a major challenge for both primary and secondary care in the future work with hypertensive patients with CVDs.
Implications for practice and further research
There is a great challenge in lowering BP in treated hypertensive patients from general practice and in treating risk factors sufficiently. This study taught us that the majority of hypertensive patients are only treated with one or two antihypertensive drugs and several diabetics were not treated according to guidelines (with ACE-I or ARB). Recommending that the GPs should titrate dose or add another antihypertensive drug class to their patients with BP above limits seems a reasonable suggestion based on this study's data. To be able to improve the overall BP control, the GP probably needs an overview of their hypertensive patients and their characteristics. An overview could for example be simplified by a population-based hypertension report identifying the patient with the highest risk both in terms of hypertension and the other risk factors like smoking, overweight and exercise. 38 This study further taught us that vulnerable populations such as diabetics need much more attention in the effort to achieve optimal BP control. Further research should investigate GP and patient-related causes for not achieving optimal BP control despite antihypertensive drug treatment.
Conclusion
In general practice in Denmark, the proportion of hypertensive patients achieving optimal BP control is inadequate. The majority of hypertensive patients are treated with only one or two antihypertensive drugs and 17.7% of hypertensive diabetics were still not treated with an ACE inhibitor or ARB.
